Former FDA head takes place on Pfizer board

Pfizer has appointed former US Food and Drug Administration (FDA) commissioner Scott Gottlieb to its board.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

FDA chief Gottlieb resigns after nearly two years

6 March 2019 Scott Gottlieb, commissioner of the US Food and Drug Administration, resigned from his post yesterday, March 5, with plans to step down in the next month.

Americas

National Cancer Institute’s director named as acting FDA chief

13 March 2019 The Trump administration has named Ned Sharpless, director of the National Cancer Institute, as the Food and Drug Administration's (FDA) acting commissioner.

Big Pharma

Pfizer off-patent division to merge with Mylan

29 July 2019 Pfizer is to merge its off-patent drug business Upjohn with Mylan, in a deal that will see Pfizer shareholders own 57% of the new company.

More on this story

Americas

FDA chief Gottlieb resigns after nearly two years

6 March 2019 Scott Gottlieb, commissioner of the US Food and Drug Administration, resigned from his post yesterday, March 5, with plans to step down in the next month.

Americas

National Cancer Institute’s director named as acting FDA chief

13 March 2019 The Trump administration has named Ned Sharpless, director of the National Cancer Institute, as the Food and Drug Administration's (FDA) acting commissioner.

Big Pharma

Pfizer off-patent division to merge with Mylan

29 July 2019 Pfizer is to merge its off-patent drug business Upjohn with Mylan, in a deal that will see Pfizer shareholders own 57% of the new company.

More on this story

Americas

FDA chief Gottlieb resigns after nearly two years

6 March 2019 Scott Gottlieb, commissioner of the US Food and Drug Administration, resigned from his post yesterday, March 5, with plans to step down in the next month.

Americas

National Cancer Institute’s director named as acting FDA chief

13 March 2019 The Trump administration has named Ned Sharpless, director of the National Cancer Institute, as the Food and Drug Administration's (FDA) acting commissioner.

Big Pharma

Pfizer off-patent division to merge with Mylan

29 July 2019 Pfizer is to merge its off-patent drug business Upjohn with Mylan, in a deal that will see Pfizer shareholders own 57% of the new company.

More features

Bayer gains exclusive licence for heart drug in Japan

EPO delivers key Novo Nordisk, GSK and Inhibrx rulings

McGuireWoods expands team with ex-Novo Nordisk GC

Paul, Weiss swoops for senior duo from Weil, Gotshal

UPC bans Meril Life Sciences from selling infringing heart valve

SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic

Kathi Vidal to rejoin previous firm as partner following USPTO departure

GSK triumphs in EPO appeal, revoking Pfizer patent

Former FDA head takes place on Pfizer board

More on this story

Editor's picks

Editor's picks

More on this story

More on this story

More features